1
Measurements: We assessed circulating GH and IGF-I levels and pituitary function at intervals after irradiation.
2
It was ascertained that the peptide was also effective in elevating the circulating GH level when administered systemically.
3
It was ascertained that fGRP-RP-2 was also effective in elevating the circulating GH and PRL levels when administered systemically.
4
The decrease in GHR levels and decreased serum IGF-I in spite of increased circulating GH suggest a state of GH resistance.